Zhiyong, Ji,
Yeping, Ling,
Pingbo, Chen,
Meng, Yuxiao,
Xu, Shancai,
Wu, Pei,
Wang, Chunlei,
Ilyasova, Tatiana,
Sun, Bowen,
Shi, Huaizhang (2023) correlation of successful recanalization.
Methods: From January 2013 to August 2021, 69 consecutive patients
monitoring (TDM) as intervention on world major clinical trials registry platform.
Methods: Cross
(hsCRP) and tumor necrosis factor-α (TNF-α) in Tatar patients (Bashkortostan).
Methods — In our case
Afolabi, A.,
Mustafina, I.,
Zhao, L.,
Li, L.,
Sun, R.,
Hu, S.,
Zhang, S.,
Jia, H.,
Guilio, G.,
Yu, B. (2018) and plaque progression is not clear.
Methods: Ninety-six nonculprit lipid-rich plaques in 69 patients who
STARODUBOV, V.I.,
MARCZAK, L.B.,
VARAVIKOVA, E.,
BIKBOV, B.,
ERMAKOV, S.P.,
GALL, J.,
GLENN, S.D.,
GRISWOLD, M.,
IDRISOV, B.,
KRAVCHENKO, M.,
LIOZNOV, D.,
LOYOLA, E.,
RAKOVAC, I.,
VLADIMIROV, S.K.,
VLASSOV, V.,
MURRAY, C.J.L.,
NAGHAVI, M (2018) factors in Russia from 1980 to 2016.
Methods We estimated all-cause mortality by use of a multistage
LIU, W.,
ZHUANG, R.,
BAI, X.,
JIA, Z.,
KAPORA, E.,
TAN, W.,
FENG, S. (2020) the effect of ASB16-AS1 on CC via regulating miR-1305.
Methods: Differentially expressed lncRNAs associated
ZHAO, L.Y.,
CHEN, X.Z.,
YANG, K.,
CHEN, X.L.,
ZHANG, W.H.,
LIU, K.,
PANG, H.Y.,
GALIULLIN, D.,
WANG, H.,
SUN, L.F.,
SONG, X.H.,
ZHOU, Z.G.,
HU, J.K.,
ZHAO, Y.L.,
YU, P.W.,
WANG, J.J.,
LI, Y.,
ZHENG, J.B.,
YAO, X.Q.,
ZHAO, Q.D.,
YI, W.Q.,
YUAN, Q. (2020) in gastric cancer patients underwent gastrectomy.
Methods: A total of 4351 patients with gastric cancer